equin
arter
viru
eav
envelop
positivestrand
rna
viru
belong
famili
arterivirida
infect
eav
requir
releas
viral
genom
fusion
respect
target
membran
host
cell
investig
entri
pathway
eav
babi
hamster
kindey
cell
bhk
infect
cell
assess
plaqu
reduct
assay
strongli
inhibit
substanc
interfer
clathrindepend
endocytosi
lysosomotrop
compound
furthermor
infect
bhk
cell
suppress
clathrindepend
endocytosi
inhibit
express
antisens
rna
clathrinheavi
chain
infect
result
strongli
suggest
eav
taken
via
clathrindepend
endocytosi
deliv
acid
endosom
compart
equin
arter
viru
eav
envelop
positivestrand
rna
viru
van
dinten
et
al
famili
arterivirida
belong
togeth
coronavirus
order
nidoviral
hors
typic
target
eav
consequ
infect
rang
asymptomat
persist
carrier
state
abort
even
lethal
haemorrhag
fever
snijder
meulenberg
eav
bud
rough
endoplasm
reticulum
outer
nuclear
membran
cell
surfac
wada
et
al
eav
contain
seven
structur
protein
essenti
viru
infect
matur
nucleocapsid
protein
n
form
isometr
core
particl
de
vri
et
al
surround
lipid
envelop
n
complex
nonglycosyl
membran
protein
major
glycoprotein
requir
viru
assembl
wieringa
et
al
put
envelop
heterotrim
glycosyl
protein
ratio
prime
candid
receptorbind
fusion
eav
envelop
cellular
target
membran
wieringa
et
al
wieringa
et
al
function
nonglycosyl
envelop
protein
e
yet
known
two
major
cell
entri
pathway
endosom
nonendosom
pathway
known
envelop
viru
deliv
viral
genom
target
cell
case
releas
viral
genom
requir
fusion
viral
envelop
respect
target
membran
host
cell
endosom
plasma
membran
membran
fusion
mediat
conform
chang
viral
protein
virus
util
nonendosom
pathway
marsh
heleniu
like
retrovirus
paramyxovirus
eg
sendai
viru
conform
chang
viral
glycoprotein
induc
interact
receptor
host
cell
surfac
therebi
trigger
fusion
viral
envelop
plasma
membran
case
virus
taken
cell
via
endosom
pathway
marsh
heleniu
acidif
late
endosom
lumen
proton
pump
activ
vtype
atpas
perez
carrasco
essenti
activ
fusion
compet
viral
glycoprotein
low
ph
trigger
conform
chang
either
directli
exampl
glycoprotein
hemagglutinin
influenza
viru
orthomyxovirus
indirectli
activ
endosom
proteas
cleav
ectodomain
viral
glycoprotein
enabl
structur
transit
fusion
compet
state
latter
mechan
describ
fusion
mediat
sprotein
sar
viru
coronavirus
simmon
et
al
virolog
recent
shown
avian
sarcomaleucosi
viru
aslv
conform
chang
fusion
mediat
protein
requir
receptor
prime
low
ph
moth
et
al
studi
investig
entri
pathway
eav
use
bhk
cell
target
influenc
substanc
interf
either
endosom
pathway
acidif
late
endosom
compart
lysosomotrop
agent
inhibitor
vacuolar
h
atpas
vtype
atpas
perez
carrasco
studi
plaqu
assay
assess
specif
role
clathrindepend
endocytosi
eav
infect
util
cell
line
induc
express
clathrin
heavi
chain
chc
antisens
rna
iversen
et
al
activ
antisens
rna
caus
block
clathrinmedi
endocytosi
data
provid
evid
clathrindepend
endocyt
pathway
major
rout
eav
cell
entri
infect
eav
requir
low
ph
trigger
investig
whether
eav
cell
entri
proce
via
endocyt
uptak
first
studi
involv
clathrinco
pit
eav
intern
use
bhk
cell
line
induc
express
antisens
rna
clathrin
heavi
chain
chc
caus
select
block
clathrindepend
endocytosi
iversen
et
al
express
antisens
chc
antichc
cell
incub
absenc
tetracyclin
see
materi
method
demonstr
repress
chcexpress
clathrindepend
endocytosi
fluoresc
transferrin
measur
effici
transferrin
uptak
observ
chc
express
cell
tc
internalis
transferrin
strongli
inhibit
cell
fig
result
confirm
previou
studi
cell
cathrindepend
endocytosi
abolish
iversen
et
al
bhkasc
tc
cell
infect
eav
infect
assess
immunofluoresc
detect
nucleocapsid
protein
n
see
materi
method
control
cell
tc
n
detect
pi
much
stronger
pi
fig
similar
observ
made
cell
shown
surmis
n
pi
origin
uncoat
disassembl
virus
infect
cell
rather
express
new
protein
n
detect
pi
correspond
newli
express
protein
cell
express
antichc
n
protein
observ
neither
pi
pi
fig
show
inhibit
clathrindepend
endocytosi
prevent
cell
infect
confirm
result
perform
infect
assay
bhkasc
cell
preincub
presenc
tc
absenc
tetracyclin
latter
case
antisens
rna
clathrin
heavi
chain
express
suppress
clathrindepend
endocytosi
alexa
fluor
transferrin
uptak
chc
express
cell
tc
display
fluoresc
transferrin
tf
high
intens
intracellular
vesicl
wherea
cell
suppress
chc
express
show
less
intens
intracellular
internalis
transferrin
uptak
measur
one
min
addit
transferrin
binfect
bhkasc
cell
eav
pi
pi
cell
fix
examin
stain
primari
antibodi
nucleocapsid
protein
tritc
label
secondari
antibodi
examin
confoc
microscopi
fluoresc
imag
record
ident
gain
set
pcphase
contrast
microscopi
dicdifferenti
interfer
microscopi
supernat
cell
monolay
incub
viru
adsorpt
harvest
probe
infect
plaqu
assay
see
materi
method
observ
strong
infect
supernat
tc
cell
could
find
plaqu
format
supernat
cell
use
data
shown
next
studi
influenc
chlorpromazin
known
abolish
format
clathrinco
endocyt
vesicl
interf
interact
adapt
protein
clathrinco
pit
lattic
wang
rothberg
anderson
chlorpromazin
well
drug
use
see
present
shortli
viru
adsorpt
subsequ
plaqu
assay
shown
fig
strong
inhibit
infect
cell
observ
upon
treatment
cell
chlorpromazin
agreement
observ
could
detect
nucleocapsid
protein
n
neither
pi
pi
chlorpromazin
treat
cell
chlorpromazin
immunofluoresc
imag
shown
absenc
detect
intracellular
n
protein
pi
chlorpromazin
treat
cell
support
strongli
earli
phase
viru
infect
inhibit
unlik
suppress
viru
product
due
inhibit
transport
viral
protein
assembl
bud
virion
contrast
eav
chlorpromazin
treatment
cell
reduc
infect
fig
belong
parainfluenza
virus
known
infect
cell
via
nonendocyt
mechan
lamb
kolakofski
result
confirm
treatment
chlorpromazin
interfer
cellular
process
least
import
viru
matur
taken
togeth
result
strongli
argu
clathrindepend
endocyt
uptak
main
cell
entri
rout
eav
base
observ
eav
enter
via
endocytosi
host
cell
ask
whether
eav
infect
requir
acid
environ
endosom
compart
end
incub
cell
substanc
prevent
endosom
acidif
use
lysosomotrop
agent
ammonium
chlorid
rel
weak
base
accumul
insid
endosom
vesicl
brindley
mauri
jin
et
al
ohkuma
pool
ii
bafilomycin
concanamycin
specif
inhibitor
vacuolar
h
atpas
vatpas
anim
eukaryot
cell
belong
macrolid
lacton
ring
antibiot
drose
altendorf
iii
monensin
ionophor
disrupt
proton
gradient
across
vesicular
membran
perez
carrasco
preincub
cell
ammonium
chlorid
reveal
inhibitori
effect
viru
reproduct
fig
incub
cell
vacuolar
h
atpas
inhibitor
bafilomycin
concanamycin
caus
also
suppress
eav
infect
fig
c
even
concanamycin
infect
complet
abolish
similar
extent
infect
suppress
observ
bafilomycin
known
concanamycin
higher
inhibitori
activ
comparison
bafilomycin
drose
altendorf
final
eav
infect
abolish
presenc
monensin
fig
plaqu
reduct
diminish
respect
control
agreement
observ
could
detect
nucleocapsid
protein
n
neither
pi
pi
monensin
treat
cell
monensin
immunofluoresc
imag
shown
henc
lysosomotrop
agent
use
show
strong
inhibitori
effect
viru
infect
contrast
eav
neither
concanamycin
bafilomycin
monensin
treatment
cell
affect
mediat
plaqu
format
fig
consist
fact
infect
parainfluenza
virus
requir
low
ph
compart
lamb
kolakofski
conclus
result
strongli
argu
eav
clathrindepend
endocyt
uptak
expos
low
ph
environ
endosom
presupposit
releas
viral
genom
cytoplasm
low
ph
compart
might
requir
expos
eav
aciddepend
proteas
ie
cathepsin
recent
report
cathepsin
cleav
sprotein
sar
simmon
et
al
filovirus
chandran
et
al
brindley
et
al
cleavag
requir
facilit
aciddepend
conform
chang
requir
activ
fusion
capac
protein
explor
whether
proteas
late
acid
compart
may
play
role
fusion
activ
eav
measur
infect
cell
upon
incub
leupeptin
shown
inhibit
acid
proteas
endosom
compart
leupeptin
competit
inhibitor
serin
cystein
proteas
irrevers
cystein
proteas
inhibitor
observ
influenc
eav
infect
concentr
leupeptin
appropri
concentr
formerli
use
inhibit
proteas
qiu
et
al
simmon
et
al
data
shown
howev
conclus
result
issu
made
studi
warrant
demonstr
inhibitor
inde
effici
suppress
endosom
proteas
sinc
endosom
proteas
activ
seem
play
role
infect
eav
plausibl
low
ph
directli
induc
conform
chang
still
unknown
glycoprotein
eav
mediat
membran
fusion
support
observ
strong
inhibit
infect
bhk
cell
virus
preincub
ph
b
fig
irrevers
loss
infect
upon
low
ph
treatment
resembl
behaviour
envelop
virus
requir
acid
ph
infect
host
cell
influenza
virus
earp
et
al
fusion
mediat
glycoprotein
hemagglutinin
influenza
viru
undergo
conform
chang
acid
ph
elev
temperatur
kort
et
al
puri
et
al
conform
chang
irrevers
abolish
fusion
activ
thu
infect
influenza
virus
infect
cell
affect
low
ph
preincub
virus
fig
known
conform
chang
fusion
mediat
f
protein
parainfluenza
virus
trigger
interact
cellular
receptor
acid
ph
lamb
kolakofski
confirm
import
role
acid
ph
infect
cell
perform
low
phbypass
experi
experi
show
whether
cell
treat
inhibitor
viru
entri
infect
trigger
fusion
virus
plasma
membran
low
ph
purpos
cell
pretreat
describ
either
chlorpromazin
concanamycin
monensin
known
inhibit
infect
cell
see
fig
viru
adsorpt
viruscel
complex
incub
min
ph
subsequ
reneutralis
see
materi
method
without
low
ph
incub
infect
almost
complet
abolish
fig
expect
see
observ
strong
infect
viruscel
complex
expos
low
ph
experi
support
low
ph
trigger
fusion
eav
virus
remark
infect
four
six
fold
higher
comparison
infect
cell
treat
inhibitor
control
without
low
ph
incub
obvious
low
ph
incub
much
effici
activ
infect
fig
influenc
preincub
acid
ph
eav
fill
circl
open
circl
incub
indic
ph
ph
neutral
viru
suspens
virus
adsorb
bhk
cell
plaqu
assay
perform
see
materi
method
data
present
mean
standard
error
estim
three
independ
experi
fig
low
phbypass
inhibit
viru
infect
bhk
cell
pretreat
describ
either
chlorpromazin
concanamycin
monensin
first
min
viru
adsorpt
ph
lower
min
neutral
viruscel
complex
incub
min
plaqu
assay
perform
describ
materi
method
controlmock
pretreat
low
ph
exposur
wowithout
low
ph
exposur
wwith
low
ph
exposur
data
present
mean
standard
error
estim
three
independ
experi
potenti
virus
comparison
natur
entri
pathway
virus
infect
cell
neither
enhanc
reduc
low
ph
exposur
data
shown
indic
also
cell
affect
temporari
acid
environ
recent
studi
provid
evid
cell
entri
envelop
virus
exampl
murin
coronaviru
choi
et
al
eifart
et
al
could
associ
lipid
domain
enrich
cholesterol
call
raft
assess
role
cholesterol
eav
entri
cell
deplet
cholesterol
preincub
methylbetacyclodextrin
see
materi
method
concentr
mm
eav
infect
complet
block
fig
furthermor
treatment
cell
filipin
iii
known
form
complex
cholesterol
membran
abolish
eav
infect
fig
control
cell
infect
vsv
enter
cell
independ
cholesterol
andor
raft
guyad
et
al
inde
cholesterol
deplet
cell
fig
treatment
cell
filipin
iii
fig
diminish
infect
vsv
notabl
found
slightli
enhanc
infect
vsv
upon
filipin
iii
treatment
find
strongli
indic
import
role
cholesterol
eav
infect
sinc
inhibitori
effect
cholesterol
deplet
could
overcom
low
phbypass
fig
conclud
cholesterol
deplet
inhibit
viru
uptak
bind
virus
cell
cholesterol
strongli
engag
clathrin
rodal
et
al
subtil
et
al
well
caveolaedepend
endocyt
pathway
yumoto
et
al
inhibit
express
clathrinheavi
chain
complet
block
infect
see
caveolaedepend
endocyt
entri
play
role
eav
uptak
henc
cholesterol
deplet
may
interfer
clathrindepend
entri
eav
summari
eav
enter
host
cell
via
clathrindepend
endcoytosi
uptak
endocyt
vesicl
deliv
late
acid
endosom
compart
low
ph
essenti
infect
cell
sinc
indic
proteas
late
compart
essenti
infect
surmis
low
ph
requir
trigger
conform
chang
structur
viru
protein
mediat
fusion
altern
might
eav
principl
fuse
neutral
ph
cellular
receptor
rapidli
endocytos
subsequ
acidif
endosom
requir
releas
viru
particl
receptor
although
structur
protein
eav
envelop
identifi
yet
known
protein
respons
mediat
fusion
complex
current
prime
candid
membranefus
activ
eav
wieringa
et
al
wieringa
et
al
one
may
wonder
whether
clathrindepend
endocytosi
typic
infect
cell
arterivirus
shown
recent
mous
hepat
virus
mhv
belong
coronaviru
famili
may
use
differ
rout
cell
entri
taken
via
clathrindepend
endocytosi
eifart
et
al
nonendocyt
internalis
describ
jhm
nash
buchmeier
kooi
etal
entri
pathway
eav
share
similar
anoth
arterivirus
porcin
reproduct
respiratori
syndrom
viru
prrsv
shown
prrsv
enter
cell
via
receptormedi
low
phdepend
endocyt
pathway
phdepend
mechan
like
describ
eav
kreutz
ackermann
nauwynck
et
al
kreutz
ackermann
found
infect
monkey
kidney
cell
line
prrsv
strongli
inhibit
presenc
cytochalasin
b
point
involv
activ
transport
prrsv
contain
endocyt
vesicl
microfila
lysosomotrop
agent
ammonium
chlorid
bafilomycin
suppress
prrsv
infect
cell
concentr
similar
use
studi
taken
togeth
result
suggest
virus
belong
famili
arterivirida
enter
cell
via
similar
endocyt
rout
cell
line
propag
adher
monolay
cultur
babi
hamster
kidney
american
type
cultur
collect
cell
grown
dulbecco
modifi
eagl
medium
dmem
cambrex
vervier
belgium
mix
one
one
leibovitz
medium
cambrex
vervier
belgium
supplement
heatinactiv
fetal
bovin
serum
hyclon
logan
ut
call
grow
media
gm
cell
maintain
humidifi
incub
co
eav
strain
bucyru
doll
et
al
grown
roller
cell
cultur
flask
roller
incub
co
adher
confluent
monolay
incub
viru
multipl
moi
serumfre
grow
media
co
adsorpt
inocula
wash
replac
gm
cell
supernat
harvest
post
infect
titer
determin
plaqu
assay
differenti
centrifug
remov
cellular
debri
sequenti
spin
min
follow
h
viru
prepar
either
use
immedi
store
phosphat
buffer
salin
pb
cambrex
vervier
belgium
influenc
storag
viru
infect
observ
clathrin
heavi
chainantisens
bhkasc
cell
line
kindli
provid
k
sandvig
institut
cancer
research
norwegian
radium
hospit
montebello
grown
complet
dmem
cambrex
vervier
belgium
supplement
heatinactiv
fetal
bovin
serum
hyclon
logan
ut
mm
lglutamin
cambrex
vervier
belgium
tetracyclin
cell
cultur
flask
co
induct
chc
antisens
rna
express
tetracyclin
remov
medium
viral
titer
determin
plaqu
assay
use
cell
indic
cell
emem
cambrex
vervier
belgium
lglutamin
sigma
berlin
germani
vv
seaplaqu
agaros
cambrex
vervier
belgium
cell
plate
plate
grown
gm
confluent
monolay
wash
pb
sequenti
dilut
viru
prepar
cell
inocul
volum
determin
plaqu
form
unit
pfu
plot
amount
plaqu
decreas
pfu
correspond
reduct
plaqu
one
order
magnitud
adsorpt
co
cell
wash
remov
also
lysosomotrop
substanc
inhibitor
see
subsequ
overlay
emem
cambrex
vervier
belgium
lglutamin
sigma
hannov
germani
vv
seaplaqu
agaros
cambrex
vervier
belgium
ad
incub
co
cell
stain
neutral
red
biochrom
berlin
germani
fix
formalin
roth
karlsruh
germani
viral
plaqu
count
control
experi
simian
parainfluenza
viru
vesicular
stomat
viru
vsv
strain
indiana
use
case
virus
eav
pretreat
h
serumfre
growth
medium
adjust
variou
acid
phvalu
citric
acid
neutral
viru
suspens
virus
adsorb
bhk
cell
plaqu
assay
perform
bafilomycin
chlorpromazin
concanamycin
filipin
iii
leupeptin
methylbetacyclodextrin
monensin
obtain
sigma
hannov
germani
ammonium
chlorid
roth
karlsruh
germani
substanc
use
within
follow
concentr
rang
bafilomycin
rang
nm
chlorpromazin
concanamycin
nm
filipin
iii
leupeptin
methylbetacyclodextrin
mm
monensin
ammonium
chlorid
mm
addit
viru
perform
plaqu
assay
cell
treat
substanc
min
gm
without
subsequ
cell
infect
presenc
differ
drug
concentr
incub
h
see
subsequ
lysosomotrop
substanc
inhibitor
wash
filipin
iii
cell
wash
pb
physiolog
conentr
mg
ca
infect
bypass
inhibitori
effect
substanc
viru
bound
bhk
cell
pretreat
substanc
h
co
describ
first
min
viru
adsorpt
ph
lower
min
neutral
viruscel
complex
incub
min
process
describ
account
strong
infect
henc
high
amount
plaqu
sequenti
dilut
viru
perform
adher
confluent
bhkasc
cell
monolay
tc
incub
viru
multipl
moi
serumfre
growth
media
co
adsorpt
inocula
wash
replac
growth
medium
cell
supernat
harvest
h
post
infect
titer
determin
plaqu
assay
use
cell
induc
express
antisens
chc
rna
antichc
bhkasc
cell
cell
incub
h
absenc
tetracyclin
control
cell
tetracyclin
present
tc
adher
confluent
bhkasc
cell
monolay
incub
viru
multipl
moi
approxim
serumfre
grow
media
co
adsorpt
inocula
wash
twice
pb
cell
fix
differ
time
point
post
infect
pb
contain
formaldehyd
subsequ
quench
mm
glycin
permeabil
triton
incub
primari
mous
monoclon
antibodi
eav
nucleocapsid
protein
vmrd
inc
pullman
usa
deregt
et
al
min
subsequ
cell
incub
appropri
tritc
label
secondari
antibodi
mous
igg
develop
goat
sigma
hannov
germani
coverslip
obtain
marienfeld
germani
confoc
fluoresc
microscopi
done
olympu
bhkasc
cell
without
remov
tetracyclin
cultur
medium
seed
observ
chamber
ibidi
martinsri
germani
incub
co
prior
experi
cultur
medium
gentli
remov
cell
exchang
transferrin
conjug
alexa
fluor
invitrogen
paisley
uk
final
concentr
dilut
medium
gm
immedi
ad
marker
dilut
cell
incub
imag
taken
confoc
phase
contrast
imag
acquir
zeiss
laser
scan
microscop
meta
mount
axiovert
invert
microscop
use
phase
contrast
oil
immers
planapochromat
object
visual
transferrin
uptak
perform
ident
condit
tc
cell
